Do FMED and INVN hold the same stocks?

By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, FMED or INVN?

FMED has 22% of its weight in S&P 500 names and INVN has 32%, so INVN differs more from the index.

Which is cheaper, FMED or INVN?

FMED charges 0.50% a year and INVN charges 0.55%, so FMED is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

FMED vs INVN: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, FMED returned +27.4% to INVN's +33.1%; 0% of their weight is in the same names.

askIQ about this page

askIQ about FMED and INVN

Net assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $9.6m on Jun 30, 2026 for Alger Russell Innovation ETF.

FMED on its own →INVN on its own →

At a glance

21.8%

FMED in the S&P 500

32.5%

INVN in the S&P 500

+27.4%

FMED total return, 1 year

+33.1%

INVN total return, 1 year

FMED · 1 year to Nov 4, 2026 78% of its weight is outside the S&P 500

22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.

INVN · 1 year to Nov 4, 2026 68% of its weight is outside the S&P 500

33% of INVN's weight is in S&P 500 companies and 68% is outside the index. Holdings as of Jun 30, 2026.

Pair scorecard

FMED costs 0.05 points a year less; their one-year returns differ by 5.7 points.

FMED vs INVN: Holdings Overlap & Returns
Measure	FMED	INVN
Return
Measure	FMED	INVN
Total return, 1 year	+27.4%	+33.1%
Benchmark
Measure	FMED	INVN
What it tracks	Broad innovation and megatrends	Broad innovation and megatrends
Cost and size
Measure	FMED	INVN
Expense ratio	0.50%	0.55%
Net assets, FMED as of Sep 30, 2026 and INVN as of Jun 30, 2026	$52m	$9.6m
Holdings
Measure	FMED	INVN
Holdings in common	0%

Method

What they share

By the books each fund has filed, FMED and INVN hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Aug 31, 2026.

50%

0 half 100%

half

0% in common

Positions both hold · largest shared weight first FMED INVN

Only in one fund ↓

Only in FMED

10X GENOMICS INC 5.19%

THERMO FISHER SCIENTIFIC INC 3.83%

DANAHER CORP 3.73%

NATERA INC 3.30%

ARGENX SE 3.20%

LIFESTANCE HEALTH GROUP INC 3.00%

REVOLUTION MEDICINES INC 2.87%

ILLUMINA INC 2.82%

Only in INVN

ROBLOX CORP 2.57%

ZEBRA TECHNOLOGIES CORP 2.38%

EXPEDIA GROUP INC 2.29%

MAPLEBEAR INC 2.25%

BLOCK INC 2.24%

ZSCALER INC 2.22%

BILL HOLDINGS INC 2.19%

BIOGEN INC 2.18%

Check overlap with more funds →

Window by window

Window by window: FMED vs INVN: Holdings Overlap & Returns
	Total return
Window	FMED	INVN
3 months	+14.9%	+9.6%
6 months	+31.2%	+33.7%
1 year	+27.4%	+33.1%
3 years	+57.8%	–
Since launchNot the same days: FMED Jun 2023 · INVN Jan 2025	+31.7%	+37.1%

– means no data for this window. Open this comparison in the app →

Side by side

FMED Fidelity Disruptive Medicine ETF · Holds 72 stocks in broad innovation and megatrends, 22% of its weight in S&P 500 companies INVN Alger Russell Innovation ETF · Holds 50 stocks in broad innovation and megatrends, 32% of its weight in S&P 500 companies

Issuer Fidelity Alger

Theme Broad innovation and megatrends Broad innovation and megatrends

In the S&P 500 21.8% 32.5%

Active share vs the S&P 500 97.5% 98.5%

In the Nasdaq-100 5.1% 7.6%

Holdings 72 50

Top ten, share of the fund 33.2% 22.6%

Expense ratio 0.50% 0.55%

Fee for the differing part 0.51% 0.56%

Total return, 1 year +27.4% +33.1%

vs its benchmark not measured not measured

Below its high −0.9% −0.9%

Net assets, FMED as of Sep 30, 2026 and INVN as of Jun 30, 2026 $52m $9.6m

As of Nov 4, 2026. Source: ETFIQ.

0% of the two portfolios are the same securities at the same weight.

Alert

About each fund

FMED

By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.

INVN

By weight, 32% of INVN's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 23% of the fund across 50 positions, as filed for Jun 30, 2026. Over the year to Nov 4, 2026 the fund returned +33.1% with distributions reinvested.

Questions people ask

Do FMED and INVN hold the same stocks?: By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, FMED or INVN?: FMED has 22% of its weight in S&P 500 names and INVN has 32%, so INVN differs more from the index.
Which is cheaper, FMED or INVN?: FMED charges 0.50% a year and INVN charges 0.55%, so FMED is cheaper. Fees come from each fund's prospectus.

Other comparisons

FMED vs BULD FMED vs DTRE FMED vs GXDW FMED vs BUYZ INVN vs ABOT INVN vs THMZ INVN vs TEKY INVN vs LENS

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →FMED on its own →INVN on its own →FMED dividend history →FMED holdings →INVN dividend history →INVN holdings →Method →Standards and sources →

Sources and dates

FMED filings on SEC EDGAR ↗

FMED prospectus with the expense ratio (SEC) ↗

Fidelity website ↗

INVN filings on SEC EDGAR ↗

INVN prospectus with the expense ratio (SEC) ↗

Alger website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, FMED against INVN, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-invn

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.